Silvana Zanlungo

Dr. Silvana Zanlungo

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
GAGraciela Arguello
Graciela Arguello
EBElisa Balboa
Elisa Balboa
MAMarco Arrese
Marco Arrese
SZSilvana Zanlungo
Silvana Zanlungo

29 April 2015 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
MAMariana Acuña
Mariana Acuña
PMPablo Martínez
Pablo Martínez
CMCarol Moraga
Carol Moraga
XHXingxuan He
Xingxuan He
MMMauricio Moraga
Mauricio Moraga
SZSilvana Zanlungo
Silvana Zanlungo
Niemann–Pick disease type B (NPDB) is a rare, inherited lysosomal storage disorder that occurs due to variants in the sphingomyelin phosphodiesterase 1 (SMPD1) gene and the resultant deficiency of acid sphingomyelinase (ASM) activity. While numerous variants causing NPDB have been described, only a small number have been studied in any detail. Herein, we describe the frequency of the p.(Ala359Asp) variant in the healthy Chilean population, and determine the haplotype background of homozygous patients to establish if this variant originated from a common founder. Genomic DNA samples from 1691 healthy individuals were analyzed for the p.(Ala359Asp) variant. The frequency of p.(Ala359Asp) was found to be 1/105.7, predicting a disease incidence of 1/44 960 in Chile, higher than the incidence estimated by the number of confirmed NPDB cases. We also describe the clinical characteristics of 13 patients homozygous for p.(Ala359Asp) and all of them had moderate to severe NPDB disease. In addition, a conserved haplotype and shared 280 Kb region around the SMPD1 gene was observed in the patients analyzed, indicating that the variant originated from a common ancestor. The haplotype frequency and mitochondrial DNA analysis suggest an Amerindian origin for the variant. To assess the effect of the p.(Ala359Asp) variant, we transfected cells with the ASM-p.(Ala359Asp) cDNA and the activity was only 4.2% compared with the wild-type cDNA, definitively demonstrating the causative effect of the variant on ASM function. Information on common variants such as p.(Ala359Asp) is essential to guide the successful implementation for future therapies and benefit to patients.

31 December 2006 in Gastroenterology
Verified
Journal Article
Closed access
LALudwig Amigo
Ludwig Amigo
JCJuan Castro
Juan Castro
JMJuan Francisco Miquel
Juan Francisco Miquel
SZSilvana Zanlungo
Silvana Zanlungo
SYStepheng Young
Stepheng Young
FNFlavio Nervi
Flavio Nervi